Combination of urinary PDG/Progesterone and LH urine testing and mobile technology for monitoring of ovulation: potential new approach?”

Presented by: Rene Leiva, MD, CD. CCFP, FCFP, Professor at University of Ottawa

 

Learning Outcomes:

  1. Explore the combination of PDG/Progesterone and LH urine testing for the dynamic monitoring of the menstrual cycle
  2. Explain the use of e-technology for complementing the menstrual cycle charting

Following this webinar, Dr. Levia's research, "Combination of Home-Based Hormonal and Mobile Technology for Virtual Monitoring of Menstrual Cycles" was published in the open-access journal, Annals of Family Medicine, following the webinar.  A supplementary document is also available at this link, which Dr. Levia and his team used to explain to patients how progesterone monitoring is used to confirm the luteal phase, as well as included links to some FABMs providers and at-home progesterone testing kits.

Cited Papers:

  1. Ecochard R, Leiva R, Bouchard T, Boehringer H, Direito A, Mariani A, Fehring R. Use of urinary pregnanediol 3-glucuronide to confirm ovulation. Steroids. 2013 Oct;78(10):1035-40. doi: 10.1016/j.steroids.2013.06.006. Epub 2013 Jul 4. PMID: 23831784.
  2. B. O'Farrell Lateral Flow Immunoassay , R. Wong and H. Tse, Humana Press, Totowa, NJ, 2009, 14–14
  3. Leiva R, Burhan U, Kyrillos E, Fehring R, McLaren R, Dalzell C, Tanguay E. Use of ovulation predictor kits as adjuncts when using fertility awareness methods (FAMs): a pilot study. J Am Board Fam Med. 2014 May-Jun;27(3):427-9. doi: 10.3122/jabfm.2014.03.130255. PMID: 24808123.
  4. Leiva R, Bouchard T, Boehringer H, Abulla S, Ecochard R. Random serum progesterone threshold to confirm ovulation. Steroids. 2015 Sep;101:125-9. doi: 10.1016/j.steroids.2015.06.013. Epub 2015 Jun 22. PMID: 26111590.
  5. Leiva RA, Bouchard TP, Abdullah SH, Ecochard R. Urinary Luteinizing Hormone Tests: Which Concentration Threshold Best Predicts Ovulation? [published correction appears in Front Public Health. 2018 Nov 30;6:345]. Front Public Health. 2017;5:320. Published 2017 Nov 28. doi:10.3389/fpubh.2017.00320
  6. Leiva, Rene & McNamara-Kilian, Marie & Niezgoda, Helen & Ecochard, Rene & Bouchard, Thomas. (2019). Pilot observational prospective cohort study on the use of a novel home-based urinary pregnanediol 3-glucuronide (PDG) test to confirm ovulation when used as adjunct to fertility awareness methods (FAMs) stage 1. BMJ Open. 9. e028496. 10.1136/bmjopen-2018- 028496.
  7. Leiva R, DiRienzo L. Combination of Home-Based Hormonal and Mobile Technology for Virtual Monitoring of Menstrual Cycles. Ann Fam Med. 2021;19(2):180. doi:10.1370/afm.2653

Dr. Rene Leiva

 

Rene Leiva (MD CM, CCFP, FCFP) is a physician and researcher based in Ottawa, Ontario, Canada.  Dr. Rene Leiva obtained his medical degree from McGill University and is an Assistant Professor with the University of Ottawa, Department of Family Medicine.  One of his main focuses of interest is modern methods of Fertility Awareness Methods and their impact on family planning and infertility. He has published several peer-reviewed research articles.

 

Continuing Medical Education Accreditation and Credit Statement:

*The AAFP has reviewed February Research Updates: Combination of urinary PDG/Progesterone and LH urine testing and mobile technology for monitoring of ovulation: a potential new approach?” and deemed it acceptable for AAFP credit. The term of approval is from February 9th, 2021 to February 9th, 2021.

  • 1.00 Online Only, Live AAFP Prescribed Credit(s) - February Research Updates: Combination of urinary PDG/Progesterone  and LH urine testing and mobile technology for monitoring of ovulation: a potential new approach?”

AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed credit, not as Category 1.

Members of the College of Family Physicians of Canada are eligible to receive 1.0  Certified or Non-Certified Mainpro+ credits for participation in this activity due to reciprocal agreement with the American Academy of Family Physicians.

The Qatar Council for Health Practitioners (QCHP) accepts the American Academy of Family Physicians (AAFP) Prescribed credit as equivalent to Category 1 – Accredited Group Learning Activities and Category 3 – Accredited Assessment Activities. When reporting AAFP Prescribed credit to the QCHP, AAFP Prescribed credit earned must be reported as AAFP Prescribed Credit equivalent to Category (1 or 3).

AAFP Prescribed credit is accepted by the following organizations. Please contact them directly about how participants should report the credit they earned.

  • American Academy of Physician Assistants (AAPA)
  • National Commission on Certification of Physician Assistants (NCCPA)
  • American Nurses Credentialing Center (ANCC)
  • American Academy of Nurse Practitioners Certification Board (AANPCB)
  • American Association of Medical Assistants (AAMA)
  • American Board of Family Medicine (ABFM)
  • American Board of Emergency Medicine (ABEM)
  • American Board of Preventative Medicine (ABPM)
  • American Board of Urology (ABU)

Webinar recordings and slides are posted to iirrm.org for those that can't attend, however, AAFP Prescribed Credit and AMA PRA Category 1 credit are only available for lecture webcasts viewed inlive, in real-time.

Disclosures

IIRRM asks all individuals, involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. IIRRM has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

Show more
Show less